Picture of PolyPeptide AG logo

PPGN PolyPeptide AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: PolyPeptide Group FY Revenue At EUR 281.0 Mln

March 14 (Reuters) - POLYPEPTIDE GROUP AG  PPGN.S :
    * H2 REVENUE FELL 0.4 PERCENT TO 281.0 MILLION EUR
    * FY REVENUE OF EUR 281.0 MILLION
    * FY ADJUSTED EBITDA^2 OF EUR 38.7 MILLION
    * FY CAPITAL EXPENDITURE OF EUR 83.0 MILLION OR 29.5% OF
REVENUE
    * 220 ACTIVE CUSTOM PROJECTS AT END OF DECEMBER 2022 (2021:
196),
WITH TWO COMMERCIAL LAUNCHES IN 2022
    * NOMINATION OF DOROTHEE A. DEURING (AUSTRIAN, 1968) AS A
NEW
MEMBER OF BOARD OF DIRECTORS TO BE PROPOSED TO AGM 2023
    * FOR 2023, POLYPEPTIDE CURRENTLY EXPECTS HIGH SINGLE-DIGIT
PERCENTAGE REVENUE GROWTH VERSUS 2022, WITH AN ADJUSTED EBITDA
MARGIN IN MID-TEENS

Source text for Eikon:  ID:nEQ8WDTtHa 
Further company coverage:  PPGN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on PolyPeptide AG

See all news